Sonova Holding AG
DUS:PHBN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Sonova Holding AG (PHBN) under the Base Case is 300.11 EUR per share.
Compared with the current market price of 308.7 EUR, the stock appears
Overvalued by 3% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sonova Does
Sonova Holding AG makes hearing care products and services. It designs and sells hearing aids, cochlear implants, wireless communication systems, and related accessories under brands used by hearing-care professionals and end customers. The company also offers audiology services and support tools that help people test, fit, and maintain their hearing devices.
- Headquarters
- Switzerland CH
- Employees
- 18 580
- IPO date
- Apr 23, 2009
Sonova Holding has no economic moat
Several established manufacturers offer competing hearing aids, and Sonova sells through independent providers as well as its own stores. Buyers and providers can therefore choose alternatives; Sonova’s brands and size alone do not keep rivals from winning sales.
Read the full moat analysisContinue PHBN Research
Decided on Sonova Holding? Get an email when PHBN reaches the price you’d buy at. Free with an account.
Other Sonova Holding listings
What is the Intrinsic Value of one PHBN stock?
The intrinsic value for
Sonova Holding AG (PHBN) under the Base Case is 300.11 EUR.
Is PHBN stock undervalued or overvalued?
Compared with the current market price of 308.7 EUR, the stock appears Overvalued by 3% .